» Articles » PMID: 31830090

Prevalence of Vitamin D Deficiency in Women from Southern Brazil and Association with Vitamin D-binding Protein Levels and GC-DBP gene Polymorphisms

Overview
Journal PLoS One
Date 2019 Dec 13
PMID 31830090
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin D deficiency is highly prevalent worldwide, and vitamin D-binding protein (DBP) a major regulator of serum vitamin D levels. The rs4588 and rs7041 polymorphisms of the GC gene constitute the genetic basis of the three major isoforms of circulating DBP (GC1s, GC1f, and GC2), while the rs2282679 variant is located in an important regulatory region of the GC gene. The aim of this study was to assess the prevalence of 25-hydroxyvitamin D [25(OH)D] deficiency and to ascertain whether it is associated with DBP levels and with GC gene variants. Biorepository samples of 443 women aged 20 to 72 years, with no evidence of clinical disease, were analyzed. Circulating levels of 25(OH)D were considered sufficient if ≥20 ng/mL and deficient if <20 ng/mL. Genotype analysis was performed by RT-PCR. Mean age was 53.4±9.4 years; mean BMI was 27.8±5.8 kg/m2. The overall sample had mean 25(OH)D levels of 22.8±8.3 ng/mL; 39.7% of participants had deficient circulating 25(OH)D levels. Higher prevalence ratios (PR) of 25(OH)D deficiency were found for the CC genotype of rs2282679 (PR 1.74; 95%CI 1.30 to 2.24; p<0.001), GC2 isoform (PR 1.66; 95%CI 1.17 to 2.38; p = 0.005), time since menopause (PR 1.02; 95%CI 1.003 to 1.03, p = 0.016), and HOMA-IR (PR 1.02; 95%CI 1.01 to 1.03, p = 0.004). DBP levels (per 30 μg/mL increase in DBP) were associated with lower PR for 25(OH)D deficiency (PR 0.89; 95%CI 0.80;0.99; p = 0.027). Except for HOMA-IR, these prevalence ratios remained significant after adjustment for age and BMI. In conclusion, the rs2282679 polymorphism and the GC2 isoform of DBP were associated with lower serum DBP levels and with susceptibility to 25(OH)D deficiency in Brazilian women with no evidence of clinical disease.

Citing Articles

Vitamin Metabolism and Its Dependency on Genetic Variations Among Healthy Adults: A Systematic Review for Precision Nutrition Strategies.

Bosch E, Sporri J, Scherr J Nutrients. 2025; 17(2.

PMID: 39861372 PMC: 11767394. DOI: 10.3390/nu17020242.


Investigating Vitamin D-Binding Protein's Role in Childhood Health and Development.

Delrue C, Speeckaert R, Delanghe J, Prytula A, Speeckaert M Int J Mol Sci. 2024; 25(11).

PMID: 38892458 PMC: 11172735. DOI: 10.3390/ijms25116272.


Association of rs2282679 polymorphism in vitamin D binding protein gene (GC) with the risk of vitamin D deficiency in an iranian population: season-specific vitamin D status.

Asghari G, Yuzbashian E, Najd-Hassan-Bonab L, Mirmiran P, Daneshpour M, Azizi F BMC Endocr Disord. 2023; 23(1):217.

PMID: 37814286 PMC: 10563356. DOI: 10.1186/s12902-023-01463-7.


Concentrations of total, bioavailable, and free 25OHD in individuals with and without primary hyperparathyroidism and their correlations to DXA and trabecular bone score.

Santos L, Ohe M, Pallone S, Nacaguma I, Kunii I, Silva R Arch Endocrinol Metab. 2023; 67(2):242-250.

PMID: 36651703 PMC: 10689035. DOI: 10.20945/2359-3997000000529.


Impact of daily vitamin D supplementation on the risk of vitamin D deficiency with the interaction of rs2282679 in vitamin D binding protein gene (GC) among overweight and obese children and adolescents: A one-year randomized controlled trial.

Asghari G, Yuzbashian E, Nikparast A, Najd Hassan Bonab L, Mahdavi M, Daneshpour M Front Nutr. 2022; 9:1061496.

PMID: 36579074 PMC: 9792175. DOI: 10.3389/fnut.2022.1061496.


References
1.
Hatse S, Lambrechts D, Verstuyf A, Smeets A, Brouwers B, Vandorpe T . Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency. Carcinogenesis. 2012; 33(7):1319-26. DOI: 10.1093/carcin/bgs187. View

2.
Casanova G, dos Reis A, Spritzer P . Low-dose oral or non-oral hormone therapy: effects on C-reactive protein and atrial natriuretic peptide in menopause. Climacteric. 2014; 18(1):86-93. DOI: 10.3109/13697137.2014.940309. View

3.
Palacios C, Gonzalez L . Is vitamin D deficiency a major global public health problem?. J Steroid Biochem Mol Biol. 2013; 144 Pt A:138-45. PMC: 4018438. DOI: 10.1016/j.jsbmb.2013.11.003. View

4.
Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, Mutschelknauss E . Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res. 2008; 10(2):R31. PMC: 2397533. DOI: 10.1186/bcr1994. View

5.
Sinotte M, Diorio C, Berube S, Pollak M, Brisson J . Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr. 2009; 89(2):634-40. DOI: 10.3945/ajcn.2008.26445. View